Cardicomm Solutions, Inc. Press Releases
TSX VENTURE SYMBOL: EKG
CardioComm Solutions Announces Shares for Service Transactions.
TORONTO, ONTARIO - August 2, 2013. CardioComm Solutions, Inc. ("CardioComm Solutions" or the "Company") (TSX VENTURE:EKG), a global medical provider of ECG acquisition and management software solutions, today announced that it has issued an aggregate of 377,129 common shares of the Company in settlement of services provided, as previously described in the Company's press release dated July 12, 2013. A total of 350,000 common shares were issued at a deemed price of $0.15 per...
CardioComm Solutions Announces Shares for Service Transactions.
TORONTO, ONTARIO -July 12, 2013. CardioComm Solutions, Inc. (“CardioComm Solutions” or the “Company”) (TSX VENTURE:EKG), a global medical provider of ECG acquisition and management software solutions, today announced that it has agreed to issue 350,000 common shares of the Company at a deemed price of $0.15 per share as compensation for $52,500 worth of services provided to the Company by an arm’s length service provider. The services provided were...
CardioComm Solutions’ HeartCheckTM PEN ECG to be used in Clinical Monitoring for Arrhythmia Risk Screening and QT interval Prolongation
ECG monitoring to be performed by Sunnybrook Hospital (Toronto) through in-home SMART Monitoring services. Toronto, Canada – CardioComm Solutions, Inc. (TSX-V:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, announced it is working with clinicians at Sunnybrook Hospital in Toronto to use the HeartCheckTM PEN handheld ECG device and SMART...
CardioComm Solutions Issues Shares in Support of Expanded HeartCheck™ Sales and Marketing Efforts in North America.
TORONTO, ONTARIO -May 21, 2013. CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), today announced that the Company has issued 29,201 shares to Mr. Simi Grosman, an independent member of the board of directors, for services rendered to the Company in the months of January, February and March of 2013. The shares were issued at a 5% premium to the closing price of the Company's shares at the end of each month. The total...
CardioComm Solutions Files New Patents for Automated Enabling of Over-The-Counter, Consumer, Bio-Monitoring Devices for Home Monitoring and Remote Diagnostic Interpretation.
The HeartCheck PEN ECG device is the first to utilize the patent pending SMART Monitoring technologies to enable/unlock a consumer medical devices to record, display, transmit and receive bio-signals and images. TORONTO, ONTARIO -May 9, 2013. CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, today...
CardioComm Solutions Establishes 30 Minute ECG Reporting Response Times as HeartCheck PEN Sales and SMART Monitoring Service Demand Grows
Leveraging national health care call centre infrastructure, North American HeartCheck PEN Consumers will have around the clock access to rapid physician ECG interpretations. TORONTO, ONTARIO – April 24, 2013. CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company"), a global medical provider of electrocardiogram ("ECG") acquisition and management software solutions, today formally announced expansion of the Company's SMART Monitoring Service...
CardioComm Solutions Issues Stock Options.
TORONTO, ONTARIO –April 19, 2013. CardioComm Solutions, Inc. (“CardioComm Solutions” or the “Company”) (TSX VENTURE:EKG), a global medical provider of ECG acquisition and management software solutions, today announced that it has issued an aggregate of 750,000 stock options. 250,000 options were issued to the Company’s CEO, Etienne Grima, in accordance with his employment, and 500,000 options were issued to senior managers of the Company. All...
